Futura Medical "on track" for launch in H1 2023

Digital Asset Direct by Futura Medical PLC

London, UK | December 13, 2022 08:08 AM Eastern Standard Time

Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Proactive to provide an update on how the company has performed during 2022, and looks ahead to what investors can expect from the coming year. He says that the company expects to go ahead with launching its erectile dysfunction treatment MED3000 during the first half of 2023.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Why News Direct

For Public Relations For Investor Relations Testimonials

About us Features News Hub

Resources

Press Blog

Why News Direct For Public Relations For Investor Relations Testimonials

What We Offer Collaborative Content Studio Advanced News Release Capability Standalone Multimedia Distribution Industry-Leading Security Unsurpassed Global Reach Actionable Analytics Synergistic PR Solutions

Pricing About us News Hub

Resources Blog Press